Hypercalcemia and hyperphosphatemia in these patients are usually due to the downstream effects of IGF-1 on the Na-Pi cotransporter in the proximal convoluted tubules of the kidneys [2,3,13]. Here, IGF1 is linked to hypercalcemia disease.